Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / @xirurgi_2025 / @xirurgi_2025 - 598 - файл

.pdf
Скачиваний:
0
Добавлен:
29.08.2026
Размер:
22 Мб
Скачать
60
https://t.me/medicina_free
However, ileostomy patients reported needing less medication. Despite this, health­care costs were three times higher for ileostomy patients than for IPAA patients. In terms of quality of life, the study found no difference when using the overall IBDQ score, but bowel symptoms-related IBDQ subscores were lower in IPAA patients. Median QALY was higher for IPAA patients, as ileostomy patients reported more frequent mobility-related problems.
According to a study by Hassab etal. [16] using data from the American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP), restorative procedures were found to have a higher rate of readmissions compared to non-restorative procedures. However, the study found that there were no signi­cant differences in other 30-day complications, including mortality rates, between the two groups.
R. Areán-Sanz and E. Messaris
Recommendations
Most patients diagnosed with ulcerative colitis who have failed medical therapy should be offered total proctocolectomy with ileal pouch-anal anastomosis with the aim of maintaining gastrointestinal tract continuity, taking into account the compa­rable rate of postoperative complications, similar quality of life parameters, and potential lower care costs.
However, certain groups of patients such as the elderly, patients with obesity, patients with multiple comorbidities, patients with a diagnosis of indeterminate colitis or Crohn’s disease, and those with previous bowel or sphincter dysfunction may not be suitable candidates for IPAA surgery due to an increased risk of compli­cations and poorer quality of life outcomes. For these patients, a total proctocolec­tomy with end ileostomy is an alternative that has similar surgical and quality of life outcomes. In patients in which IPAA surgery is contraindicated and an end­ileostomy is either refused or contraindicated, an ileo-rectal anastomosis (IRA) is an alternative procedure.
It’s important to note that, despite a potentially higher incidence of surgical com­plications and inferior quality of life outcomes than primary pouch creation, a revi­sional procedure, or re-do IPAA, can still benet patients who failed primary IPAA surgery.
Personal View
Total proctocolectomy with IPAA should be the procedure of choice in most cases; however, it’s vital to keep complications and populations at risk in mind when selecting candidates for this procedure. Multiple studies have been published that evaluate the predictive factors for short- and long-term complications, poor quality of life measures, and mortality for patients with UC who underwent IPAA as cura­tive treatment.
5 Which Patients withUlcerative Colitis Benet fromIleal Pouch-Anal Anastomosis?
https://t.me/medicina_free
In a retrospective review of 116 patients followed for 10 years, the authors reported a 30-day complication rate of 16.4%. Fifty-seven percent of patients pre­sented late adverse events —chronic pouchitis being the most frequent (23.3%), followed by intestinal obstruction (17.2%) and perianal stula (13%)—. The study also evaluated functional outcomes using the Öresland scale and the Cleveland Global Quality of Life Scale. The results indicate that 75% of the study cohort reported that their social life was not compromised by the procedure and 92.7% of patients were satised with the results and would recommend the procedure to other patients who might benet from it [17].
Male sex, older age, higher body-mass index, and extraintestinal manifestations have been associated with failure of IPAA. (1,7) Moreover, the use of steroids before colectomy may be a risk factor for anastomotic leak, stula formation, and pouch failure [6].
Using the IBD-disability index, Kayal etal. [2] reported that 37.2% of patients who underwent an IPAA creation for UC had moderate to severe disability. Certain aspects, such as overall health, sleep, energy, regulating defecation, and pain were found to be particularly affected when compared to patients receiving medical treat­ment alone. The study also found that certain patient groups were more likely to experience higher levels of disability, such as women, patients with active symp­toms, and those with public insurance.
61
Patients withObesity
Up to 32% of patients diagnosed with UC have a BMI>30 and this population has been traditionally considered at high risk for complications and failure of IPAA. Although there is no consensus on whether functional outcomes such as incontinence, frequency of bowel movement, pad usage, and pouchitis are signi­cantly different between patients with obesity and patients without, studies have found that the former are more likely to undergo open IPAA surgery and have lon­ger operative times, greater rates of complications (mainly surgical site and urinary tract infections), as well as more blood transfusion requirements and longer length of stay [18]. Furthermore, studies using the ACS-NSQIP database of patients who underwent IPAA for UC have found that obesity is an independent factor associated with higher rates of organ space sepsis and readmission for infectious complications [19, 20]. Similar ndings were reported by Abd el Aziz etal. [21] which also found higher rates of postoperative organ space infections in patients with obesity. In con­trast, all the other complications included in their multivariate analysis showed no difference when compared with patients with a BMI<30. The poor surgical out­comes in this population are mainly due to intraoperative technical difculties such as a short mesentery length (due to adiposity or inammation, regarded as the most common direct cause), as well as a limited working space in a narrow pelvis, which can sometimes lead to deferring the surgery until after the patient has lost excess weight [1, 21].
62
https://t.me/medicina_free
More recently, a retrospective multivariable analysis of 2202 patients found that patients with obesity had longer surgical times, lower pouch survival and, most importantly, they found that obesity was the strongest independent predic­tor of pouch failure (HR 4.24). Global quality-of-life scores were also lower than in patients without. The authors did not, however, nd an independent associa­tion between obesity and postoperative complications (dened as a composite outcome of any complication), in-hospital length of stay or anastomotic leak. [22]
Taking the aforementioned reports into account, patients with a BMI<30 should be offered IPAA surgery, whereas caution should be taken when deciding whether or not this procedure is recommended for patients with a BMI between 30 and 35. For patients with a BMI over 35, other than carefully selected exceptions, pouch surgery should not be offered given the higher risk of complications and negative quality of life impact. On the other hand, weight loss management can convert these high-risk patients to low-risk when BMI becomes <30 or<35in some cases.
R. Areán-Sanz and E. Messaris
Elderly Patients
There is still no consensus in terms of an age cut-off at which IPAA should not be recommended, given that there are multiple factors associated with complications and/or failure, and age alone does not seem to impact as much as previously thought. Nonetheless, there still seems to be a tendency to recommend end ileostomy proce­dure to elderly patients. When comparing rates of procedure choice (IPAA vs ileos­tomy), Cohan etal. [23] found that older age patients received ileostomy more often than IPAA, given the notion that the risks of the latter are higher; however, more elderly patients have been undergoing IPAA over time.
In 2016, Bollegala etal. [24] published a comparative analysis of postoperative outcomes in patients diagnosed with IBD and found that 30-day mortality among elderly patients was almost 10 times higher than in non-elderly patients (5.3% vs
0.5%); in-hospital mortality was also found to be signicantly higher for this group of patients (3.3% vs 0.4%). The authors reported higher rates of postoperative com­plications in elderly IBD patients. Emergent surgery in elderly patients diagnosed UC presented ve-fold risk mortality rates in comparison to the non-elderly group. Still, this study’s ndings are limited given a lack of information regarding disease severity and previous medical treatments; moreover, as mentioned by Piper etal. [25], it is unclear whether the ndings of Bollegala etal’s study correspond to spe­cic risks posed by the surgical treatment of IBD, or if they are those inherent to abdominal surgical procedure in the elderly population. This study’s results are not consistent with previous and more recent reports. For instance, Cohan etal. [26] published an ACS-NSQIP analysis comparing patients aged 50 or younger against patients aged 51–60 and>60, as well as based on frailty trait count. They found no signicant differences in terms of complication rate other than a 0.8-day longer length-of-stay at the hospital for the >60 group, which, although statistically signi­cant, is not clinically relevant. Frailty trait count showed no association with either complication rates or length of stay.
5 Which Patients withUlcerative Colitis Benet fromIleal Pouch-Anal Anastomosis?
https://t.me/medicina_free
More recently, Lightner etal. [27] published an analysis of 1875 patients with a median follow-up of 16.1years after IPAA.For patients aged 65 or older who had undergone IPAA surgery, 47% reported complete lack of incontinence, 36% pre­sented occasional incontinence, and only 17% reported frequent incontinence throughout the day. At night, rates of no, occasional, and frequent incontinence episodes were 25%, 43%, and 33%, respectively.
When it comes to differences among elderly subgroups, Minagawa etal. [28] compared functional outcomes in patients aged 65–69 vs aged 70 and older and found no signicant difference regarding stool frequency, and daytime/nighttime soiling.
Age should not be the sole factor in determining whether a patient is suitable for ileal pouch-anal anastomosis (IPAA) surgery, as multiple studies and a systematic review published in 2021 have found. The review, conducted by Pedersen in 2021 [29], analyzed 13 studies and found no statistically signicant difference between elderly (65 and older) and non-elderly patients in terms of short-term and long-term complications after IPAA surgery. Instead, other factors such as comorbidities, functional status, pre-operative bowel function, and patient preference should be considered when making the decision to proceed with IPAA surgery.
63
Sphincter Abnormalities
The restorative nature of IPAA surgery poses the benet of preserving sphincter function; still, up to 30% of patients report some degree of fecal incontinence. Certain patient populations, such as the elderly and those with a history of obstetric complications, may be at higher risk for continence issues following the surgery. This is likely due to potential preoperative sphincter abnormalities in these groups [7]. A retrospective study that included patients who had had pouch surgery for over 30years found that patients older than 80years of age did not have higher rates of fecal incontinence but did report increased episodes of seepage and more frequent use of pads during both day and night [30].
An anorectal manometry is not always required, but a digital rectal examination should be performed to evaluate sphincter tone before determining suitability for an IPAA procedure. Patients with preoperative altered sphincter tone may be better suited for a non-restorative procedure; however, this decision should be made after a thorough discussion of postoperative expectations with the patient [7]. If a perma­nent stoma is not accepted by the patient, an IRA is a viable option in this group of patients.
Primary Sclerosing Cholangitis
The outcomes of IPAA for patients with both ulcerative colitis (UC) and primary sclerosing cholangitis (PSC) are not well understood. While these patients may have a higher rate of pouch dysfunction and pouchitis, there does not appear to
64
https://t.me/medicina_free
be a signicant difference in surgical complications when compared to other groups. However, a study by Pavlides etal. [31] found that patients with UC and PSC reported signicantly higher rates of nighttime bowel movements. On the other hand, a large cohort study comparing restorative procedures for patients with UC and PSC found no statistically signicant difference in terms of pouch failure, with failure rates of 4%, 11%, and 18% at 1, 3, and 5years, respectively [32]. Patients with UC and PSC should be treated as patients with UC and without PSC.
R. Areán-Sanz and E. Messaris
Patients withIndeterminate Colitis or Crohn’s Disease
Patients who underwent pouch surgery can develop postoperative inammation of the pouch with features similar to Crohn’s disease (CD), a complication controver­sially referred to as “CD of the pouch” [33, 34]. However, it is important to distin­guish between actual CD of the pouch (i.e., a patient with preoperative diagnosis of CD or a patient with a preoperative diagnosis of UC or indeterminate colitis (IC) whose colectomy specimen was diagnosed as CD) versus a pouch with CD-like features. Suggestive features for the former include pre-pouch ileitis; development of stulas and abscesses 6–12months after ileostomy takedown; strictures, segmen­tal or skip lesions affecting the pouch or small intestine; and non-caseating granulo­mas in the pouch or cuff [34, 35]. Postoperative (de novo) CD has been reported in up to 15.9% of patients who undergo IPAA for UC, and their outcomes differ from those patients where CD diagnosis was already established [36, 37].
Patients with a preoperative diagnosis of CD who undergo pouch creation have a risk of complications such as stulas, strictures, and abscesses, and end-ileostomy is the preferred procedure in most cases where colectomy is needed. However, cer­tain patients may benet from IPAA surgery, mainly those without perianal or small bowel involvement (occurring in up to 20% of cases) [35, 38]. Information on patients preoperatively diagnosed with CD who have undergone IPAA is limited and most studies report results of patients with original diagnosis of UC or indeter­minate colitis (IC) [36]. The risk of pouch failure is higher in patients with CD and has been reported in up to 15% of patients, a rate signicantly higher than that of patients with UC.Due to this, some experts prefer IRA over IPAA in patients with indeterminate colitis without rectal involvement to avoid the potential pouch failure if the patient is postoperatively diagnosed with CD.However, other complications and long-term functional outcomes appear to be similar to those reported for patients with UC [37]. Therefore, patients with a preoperative CD diagnosis with no perianal or small bowel disease who undergo IPAA should be closely monitored for adverse events and complications. Specically, for patients with CD in which the pouch did not fail, complication rates and functional outcomes are comparable to those in patients with UC [38]. Biologic medications can be used to maintain the disease in remission and increase IPAA retention.
Re-doing IPAA after a failed primary restorative procedure in patients with pre­operative CD may be a viable option for specic patients given acceptable quality
5 Which Patients withUlcerative Colitis Benet fromIleal Pouch-Anal Anastomosis?
https://t.me/medicina_free
of life outcomes, although complication rates are higher for this group compared to re-doing IPAA in patients with UC [39].
65
Patients ofChildbearing Age
There have been reports of higher infertility rates after IPAA surgery in patients of childbearing age, although the evidence behind this has been inconclusive. Some surgeons offer these patients an IRA as an alternative to IPAA with the same pur­pose of restoring the GI tract while lowering the risk of postoperative infertility [40]. However, the proposed advantage in fertility supporting IRA is debatable, with some studies showing no difference between the two procedures. For instance, a recent large observational study compared the impact of IPAA and IRA in preg­nancy rates, and also compared them with a control group of people who had under­gone appendectomy. After adjusted analysis, they found that both procedures for UC increased the rate of infertility versus the control population, yet reported no difference between IPAA and IRA [41]. It’s important to note that any restorative procedure for UC can decrease fertility. Patients may choose to delay restoration with IPAA or IRA until after they no longer wish to have more children.
Redo IPAA
There is limited information available on the effectiveness of re-doing an IPAA pro­cedure for patients who have previously failed primary IPAA surgery. The main indi­cation for this is patients with failed IPAA with a signicant aversion to living with a permanent stoma. Moreover, if re-do IPAA surgery is unsuccessful, another attempt at a restorative procedure may be considered. The long-term outcomes in patients who have undergone an IPAA revision after failed re-do IPAA appear to be similar to re-do IPAA procedures in terms of pouch survival rate and patient quality of life, making revision after a failed re-do IPAA a safe and viable option for this patient population [42]. It’s worth noting that pouch excision after a failed IPAA creation is also linked with increased morbidity and reduced quality of life. [43] For selected patients, re-do of the IPAA is the best option in order to preserve the gastrointestinal continuity.
Conclusion
In conclusion, total proctocolectomy with ileal pouch-anal anastomosis offers com­parable postoperative complications, quality of life, and potentially lower care cost to patients in need of surgery for ulcerative colitis as measured against total procto­colectomy and end ileostomy and should be offered to most patients with an indica­tion for surgical treatment of ulcerative colitis. The decision-making process should take into account several patient characteristics which could affect the surgical mor­bidity and overall quality of life of patients undergoing restorative proctocolectomy.
66
https://t.me/medicina_free
R. Areán-Sanz and E. Messaris
References
1. Frese JP, Gröne J, Lauscher JC, Konietschke F, Kreis ME, Seifarth C.Risk factors for fail­ure of ileal pouch-anal anastomosis in patients with refractory ulcerative colitis. Surgery. 2022;171:299–304.
2. Kayal M, Ungaro RC, Riggs A, Kamal K, Agrawal M, Cohen-Mekelburg S, etal. Ileal pouch anal anastomosis for the management of ulcerative colitis is associated with signicant dis­ability. Clin Gastroenterol Hepatol. 2022;20:e761–9.
3. Holubar SD, Lightner AL, Poylin V, Vogel JD, Gaertner W, Davis B, etal. The American Society of Colon and rectal surgeons clinical practice guidelines for the surgical management of ulcerative colitis. Dis Colon Rectum. 2021;64:783–804.
4. Lee GC, Deery SE, Kunitake H, Hicks CW, Olariu AG, Savitt LR, etal. Comparable periopera­tive outcomes, long-term outcomes, and quality of life in a retrospective analysis of ulcerative colitis patients following 2-stage versus 3-stage proctocolectomy with ileal pouch-anal anasto­mosis. Int J Color Dis. 2019;34:491–9.
5. Baker DM, Folan AM, Lee MJ, Jones GL, Brown SR, Lobo AJ.A systematic review and meta­analysis of outcomes after elective surgery for ulcerative colitis. Color Dis. 2020;23:18–33.
6. Lim MH, Lord AR, Simms LA, Hanigan K, Edmundson A, Rickard MJFX, etal. Ileal pouch­anal anastomosis for ulcerative colitis: an Australian institution’s experience. Ann Coloproctol. 2021;37:318–25.
7. Chang S, Shen B, Remzi F.When not to pouch: important considerations for patient selection for ileal pouch-anal anastomosis. Gastroenterol Hepatol (N Y). 2017;13(8):466–75. PMID: 28867978; PMCID: PMC5572960
8. Emblem R, Larsen S, Torvet SH, Bergan A.Operative treatment of ulcerative colitis: conven­tional proctectomy with Brooke ileostomy versus mucosal proctectomy with ileoanal anasto­mosis. Scand J Gastroenterol. 1988;23:493–500.
9. McLeod RS, Churchill DN, Lock AM, Vanderburgh S, Cohen Z.Quality of life of patients with ulcerative colitis preoperatively and postoperatively. Gastroenterology. 1991;101:1307–13.
10. Liddell A, Pollett WG, MacKenzie DS. Comparison of postoperative satisfaction between ulcerative colitis patients who chose to undergo either a pouch or an ileostomy operation. Int J Rehabil Heal. 1995;1:89–96.
11. O’Bichere A, Wilkinson K, Rumbles S, Norton C, Green C, Phillips RK.Functional outcome after restorative panproctocolectomy for ulcerative colitis decreases an otherwise enhanced quality of life. Br J Surg. 2000;87:802–7.
12. Nordin K, Påhlman L, Larsson K, Sundberg-Hjelm M, Lööf L.Health-related quality of life and psychological distress in a population-based sample of Swedish patients with inamma­tory bowel disease. Scand J Gastroenterol. 2002;37:450–7.
13. Camilleri-Brennan J, Munro A, Steele RJ.Does an ileoanal pouch offer a better quality of life than a permanent ileostomy for patients with ulcerative colitis? J Gastrointest Surg. 2003;7:814–9.
14. Kuruvilla K, Osler T, Hyman NH.A comparison of the quality of life of ulcerative colitis patients after IPAA VS ileostomy. Dis Colon Rectum. 2012;55:1131–7.
15. van der Valk ME, Mangen M-JJ, Severs M, van der Have M, Dijkstra G, van Bodegraven AA, etal. Comparison of costs and quality of life in ulcerative colitis patients with an ileal pouch­anal anastomosis, ileostomy and anti-TNFα therapy. J Crohn’s Colitis. 2015;9:1016–23.
16. Hassab T, McKinney D, D’Adamo CD, Svoboda S, Katlic M, Wolf JH.Short-term outcomes for restorative and non-restorative proctocolectomy in older adults. J Surg Res. 2022;269:11–7.
17. Carcamo L, Miranda P, Zuniga A, Alexander E, Molina ME, Urrejola G, etal. Ileal pouch-anal anastomosis in ulcerative colitis: outcomes, functional results, and quality of life in patients with more than 10-year follow-up. Int J Color Dis. 2020;35:747–53.
18. McKenna NP, Mathis KL, Khasawneh MA, Dozois EJ, Larson DW, Pemberton JH, etal. Obese patients undergoing ileal pouch-anal anastomosis. Inamm Bowel Dis. 2017;23:2142–6.
19. McKenna NP, Glasgow AE, Cima RR, Habermann EB.Risk factors for organ space infection after ileal pouch anal anastomosis for chronic ulcerative colitis: an ACS nsqip analysis. Am J Surg. 2018;216:900–5.
5 Which Patients withUlcerative Colitis Benet fromIleal Pouch-Anal Anastomosis?
https://t.me/medicina_free
20. McKenna NP, Habermann EB, Glasgow AE, Mathis KL, Lightner AL.Risk factors for read­mission following ileal pouch-anal anastomosis: an American College of Surgeons National Surgical Quality Improvement Program analysis. J Surg Res. 2018;229:324–31.
21. Abd El Aziz MA, Calini G, Grass F, Behm KT, D’Angelo A-L, Shawki S, etal. Minimally invasive ileal pouch-anal anastomosis for patients with obesity: a propensity score-matched analysis. Langenbeck’s Arch Surg. 2021;406:2419–24.
22. Leeds IL, Holubar SD, Hull TL, Lipman JM, Lightner AL, Sklow B, etal. Short- and long­term outcomes of ileal pouch anal anastomosis construction in obese patients with ulcerative colitis. Dis Colon Rectum. 2022;65:e782–9.
23. Cohan JN, Bacchetti P, Varma MG, Finlayson E.Impact of patient age on procedure type for ulcerative colitis. Dis Colon Rectum. 2015;58:769–74.
24. Bollegala N, Jackson TD, Nguyen GC.Increased postoperative mortality and complications among elderly patients with inammatory bowel diseases: an analysis of the National Surgical Quality Improvement Program cohort. Clin Gastroenterol Hepatol. 2016;14:1274–81.
25. Piper MS, Waljee AK, Stidham RW.Operate or medicate: understanding surgical risks in the elderly with inammatory bowel disease. Gastroenterology. 2016;151:1029–30.
26. Cohan JN, Bacchetti P, Varma MG, Finlayson E.Outcomes after ileoanal pouch surgery in frail and older adults. J Surg Res. 2015;198:327–33.
27. Lightner AL, Mathis KL, Dozois EJ, Hahnsloser D, Loftus EV, Raffals LE, etal. Results at up to 30 years after ileal pouch-anal anastomosis for chronic ulcerative colitis. Inamm Bowel Dis. 2017;23:781–90.
28. Minagawa T, Ikeuchi H, Kuwahara R, Horio Y, Sasaki H, Chohno T, etal. Functional outcomes and quality of life in elderly patients after restorative proctocolectomy for ulcerative colitis. Digestion. 2019;101:737–42.
29. Pedersen KE, Jia X, Holubar SD, Steele SR, Lightner AL.Ileal pouch-anal anastomosis in the elderly: a systematic review and meta. Äêanalysis Color Dis. 2021;23:2062–74.
30. Lightner AL, Steele SR, McMichael JP, Jia X, Qazi T, Click BH, etal. Pouch function over time and with advancing age. Dis Colon Rectum. 2022;65:254–63.
31. Pavlides M, Cleland J, Rahman M, Christian A, Doyle J, Gaunt R, etal. Outcomes after ileal pouch anal anastomosis in patients with primary sclerosing cholangitis. J Crohn’s Colitis. 2014;8:662–70.
32. Nordenvall C, Olén O, Johan Nilsson P, Ekbom A, Bottai M, Myrelid P, et al. Restorative surgery in patients with primary sclerosing cholangitis and ulcerative colitis following a colec­tomy. Inamm Bowel Dis. 2018;24:624–32.
33. Shehab M, Alrashed F, Charabaty A, Bessissow T.Biologic therapies for the treatment of post­ileal pouch anal anastomosis surgery chronic inammatory disorders: systematic review and meta-analysis. J Can Assoc Gastroenterol. 2022;5:287–96.
34. Akiyama S, Dyer EC, Rubin DT.Diagnostic and management considerations for the IPAA with Crohn’s disease-like features. Dis Colon Rectum. 2022;65:S77–84. https://doi.org/10.1097/
dcr.0000000000002547.
35. Shaffer SR, Bernstein CN.Controversies in Crohn’s disease before and after pouch surgery. Dis Colon Rectum. 2022;65:S45–9. https://doi.org/10.1097/dcr.0000000000002550.
36. Lopez NE, Zaghyian K, Fleshner P.Is there a role for ileal pouch anal anastomosis in Crohn’s disease? Clin Colon Rectal Surg. 2019;32:280–90.
37. Lightner AL, Jia X, Zaghiyan K, Fleshner PR.IPAA in known preoperative Crohn’s disease: a systematic review. Dis Colon Rectum. 2020;64:355–64.
38. Connelly TM, Lincango E, Holubar SD.Crohn’s of the pouch: now what? Clin Colon Rectal Surg. 2022;35:475–86.
39. Lavryk OA, Stocchi L, Shawki S, Aiello A, Church JM, Steele SR, Hull TL. Redo IPAA after a failed pouch in patients with crohn’s disease: is it worth trying? Dis Colon Rectum. 2020;63:823–30.
40. Faye AS, Oh A, Kumble LD, Kiran RP, Wen T, Lawlor G, Lichtiger S, Abreu MT, Hur C. Fertility impact of initial operation type for female ulcerative colitis patients. Inamm Bowel Dis. 2019;26:1368–76.
67
68
https://t.me/medicina_free
41. Challine A, Voron T, O’Connell L, Chafai N, Debove C, Collard M, Parc Y, Lefèvre JH.Does an ILEO-anal anastomosis decrease the rate of successful pregnancy compared to an ileorectal anastomosis? A national study of 1,491 patients. Ann Surg. 2022;277:806–12. https://doi.
org/10.1097/sla.0000000000005569.
42. Esen E, Lynn PB, Da luz Moreira A, Erkan A, Aytac E, Grieco MJ, etal. Operative, long-term and quality of life outcomes after salvage of failed re-do ileal pouch anal anastomosis. Color Dis. 2022;24:790–2.
43. Carpenter H, Hotouras A, English WJ, Taylor FG, Andreani S.Revisional ileoanal pouch surgery: a systematic literature review assessing outcomes over the last 40 years. Color Dis. 2021;23:52–63.
R. Areán-Sanz and E. Messaris
Persistent Posterior Sinus After Ileal
https://t.me/medicina_free
Pouch-Anal Anastomosis
KathrynE.Chuquin andBrianL.Bello
Introduction
Ileal pouch-anal anastomosis (IPAA) is the preferred reconstructive option to main­tain continence after proctocolectomy for inammatory bowel disease or familial adenomatous polyposis syndrome. IPAA has many documented complications, one of which is formation of a posterior sinus tract. This is a blind-ending tract usually in the presacral space originating from the pouch-anal anastomosis that most fre­quently forms as a sequela of a contained anastomotic leak. Incidence of posterior sinus after IPAA has been reported to range from 2–8% [13], with persisting sinus a signicant predictor of pouch failure [2]. Pouch sinus is routinely diagnosed when performing a Gastrogran enema (or pouchoscopy) prior to consideration of divert­ing loop ileostomy closure. Management of a posterior sinus can be difcult and ranges from observation to pouch excision depending on the size and complexity of the sinus, patient symptoms, and surgeon expertise.
6
Search Strategy
A comprehensive search of PubMed, EMBASE, MEDLINE and Cochrane Database was performed to include the last 25years (1997–2022). Results were limited to English language and peer-reviewed publications. Additional studies were identi­ed using the references sections from the initially identied papers. Search terms
K. E. Chuquin Washington, DC, USA
B. L. Bello (*) Medstar Medical Center, Washington, DC, USA e-mail: brian.l.bello@medstar.net
© The Author(s), under exclusive license to Springer Nature Switzerland AG 2023 K. Umanskiy, N. Hyman (eds.), Difcult Decisions in Colorectal Surgery, Difcult Decisions in Surgery: An Evidence-Based Approach,
https://doi.org/10.1007/978-3-031-42303-1_6
69